Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Neoplasm, Breast|Breast Diseases
Interventions: DRUG: Pyrotinib|DRUG: Trastuzumab|DRUG: Docetaxel|DRUG: Carboplatin|DRUG: Placebo Oral Tablet
Sponsor: Zhejiang Cancer Hospital